Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd. is a fast-growing developer, producer, and distributor of bio-pharmaceutical products in China. Since 1989 the company successfully established its national and international vaccine business with the intention to provide high quality vaccines of international standard, and contribute to the prevention of diseases in China and throughout the world.
Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd. is a limited liability company, which is mainly invested by private capital in China. At present, the company is one of China's largest private manufacturers of influenza vaccine.
With about 247 employees the company is producing viral and bacterial vaccines in state-of-the-art manufacturing facilities meeting both national and international quality standards. All manufacturing lines of Tianyuan have been granted with cGMP certificates from the State Food and Drug Administration (SFDA) of China.
The company wants to further expand its market beyond China to other countries and strives for cooperation with international vaccine distributors. Since 2005 the company has sold its influenza vaccine in Macau and since 2006 it has been sold to Eastern European and South American markets. The product has been registered in several countries including India and Macedonia, where it got export permission.
Tianyuan's approach for R&D includes the integration of knowledge and experiences from foreign experts. It is the company's goal to fast-track R&D and the optimization of our current processes to reach internationally competitive products.
Tianyuan is preparing for WHO pre-qualification. It is the company's aim is to go for internationalization and become a recognized global player in the field of vaccines.
Tianyuan wants to extend its cooperation network to national as well as international research institutions and vaccine manufacturers.
Interested parties are welcome for visits and exchange of experiences. We are open for technology transfer and licensing of key technologies and vaccine processes.